Key Takeaways
- Revenue missed budget by ~7% as European auto headwinds and OEM inventory corrections hit harder than expected, forcing a mid-year growth target cut from 30-35% to 16%.
- Profitability compressed sharply: PBT fell ~50% YoY because depreciation and finance costs on committed investments could not be absorbed by the lower sales volume.
- The BMW electric sports car nomination is the quarter's strategic win, marking RACL's second German passenger-vehicle OEM nomination in six months and a deliberate pivot toward premium PV and CV segments.
- Cash flow stayed healthy despite the P&L hit: cash from operations rose 83% to ₹19.8 crores in H1, and management expects net debt to reduce by ₹20 crores this year.
- What to watch next quarter: Whether the green shoots in snowmobile/ATV orders materialize into a broader European recovery, the pace of domestic business ramp-up, and clarity from management's planned Europe visit before Christmas.
European Auto Headwinds
- Multiple shocks compressed demand: High energy costs in Germany (electricity 3x India's), Red Sea crisis adding 40-45 days to shipments, geopolitical risks from Russia-Ukraine and Israel, and Chinese dumping all hit European OEMs simultaneously.
- EV adoption confusion froze purchase decisions: European consumers are delaying vehicle purchases because promised EV infrastructure was not built and the regulatory push toward EVs has not been matched by market readiness. Management believes ICE and EVs will now coexist rather than one replacing the other.
- OEM inventory correction amplified the slowdown: During COVID, OEMs overproduced and built dealer inventories; they are now correcting from the input side by ordering less from suppliers like RACL, even though retail sales at dealerships have not declined. RACL has started controlling its own production in response.
- Green shoots are tentative and segment-specific: November forecasts from one ATV/snowmobile customer picked up on predictions of heavy snow in the Northern Hemisphere, but management describes the overall situation as "mixed" with some segments showing no visibility and others showing early signs. A planned Europe visit aims to get realistic customer numbers before Christmas.
Gursharan Singh: "Technically, I'll say that whatever huge growth was showing visible in COVID times on this OEMs, that growth has undoubted, but there's not really decline at the retail level is good, but it is early across all the sectors."
Strategic Pivot: Premium Segments & Domestic Market
- Product mix shifting from 2-wheelers to PV and CV: The company is deliberately moving toward bigger products with longer manufacturing periods and higher value-add, reducing dependence on the high-volume but lower-value 2-wheeler segment.
- BMW nomination is the flagship of this pivot: RACL won a nomination to supply drivetrain parts for a BMW electric sports car, described as "a different level of performance" and "a big wave" that is expected to change the company's numbers and accelerate passenger-car diversification. This is the second German PV OEM nomination in six months.
- Domestic business is being developed as a counterweight to export headwinds: Management is deploying unutilized capacity to ramp up domestic sales, accepting slightly lower per-piece margins in exchange for faster receivable recovery (exports tie up cash for 75-80 days shipping plus 30 days credit). The domestic focus is on premium motorcycles (300CC-500CC+), not commoditized 100CC bikes.
- Premium domestic bike supply is already material: RACL supplies 100% of the gearbox for Piaggio's RS 457 (ramping to "big numbers" from January), Aprilia's new 660CC bike, and Yamaha's bike launched at AKAMA 2024. Discussions are underway with domestic passenger car makers and for industrial/medical segments including CT scanner gears.
Gursharan Singh: "Domestic margins have been very competitive, but then you get better receivable management, you get money pretty fast. So somewhere it balances out all the stuff."
Project Titan & New Business Pipeline
- Project Titan is on schedule: First sample phase completed successfully in under six months with customer approval; second trial phase set for February 2025; line completion expected January 2025 with machines already ordered; mass production targeted for August 2026.
- Second new nomination received with mass production expected "somewhere in the middle of year 2027"; management declined to quantify revenue, citing dependence on customer base and product type.
- New customer discussions span multiple segments: Serious discussions with domestic passenger car makers, medical equipment manufacturers (CT scanners), and heavy industrial customers, alongside existing production of gears for circuit breakers. Management asked for "another couple of calls" before disclosing details.
- Customer concentration risk is mitigated by end-brand diversification: While RACL has only 22 direct customers, each supplies multiple end-brands (ZF supplies Mercedes, BMW, Aston Martin, Rolls Royce; MAN supplies Daimler/Scania), keeping individual end-brand exposure at 2-3%.
Gursharan Singh: "This car is at a different level of performance. Different level of premiumness and... customer is of course BMW projecting very high numbers."
Margins & Cost Structure
- Fixed-cost base amplified the revenue miss: Depreciation and finance costs rose on investments already made, and these could not be absorbed when sales came in ~₹8 crores below budget. Employee costs also rose because management chose not to discontinue increments and hiring commitments despite short-term pressure.
- Raw material pass-through provides a partial offset: Steel price increases were passed through to customers, and consumption of raw material improved in Q2 versus last year; on a full-year basis this will help margins.
- Domestic margins will be lower than export margins but are not comparable to commoditized 2-wheeler supply because RACL targets premium segments where customers come to them. Management declined to give a generic margin expectation, saying each product component has different costing.
- Other income of ₹4.2 crores included tooling income from prototyping/nominations and foreign exchange fluctuations, providing some cushion to the bottom line.
Jitender Jain: "We have to do increments. We have to do as per the talent for the future we can't create. The salary disparities because of short term issues, so we will not discontinue our commitments there."
Balance Sheet & Capital Allocation
- Cash generation improved despite P&L pressure: Cash from operations rose 83% to ₹19.8 crores in H1, signaling that underlying working capital management is healthy.
- Net debt reduction of ₹20 crores is planned this year, with management working on additional structures that cannot yet be disclosed.
- Investment deferral in line with market conditions: Some planned investments have been postponed from this year to next year, matching the slower revenue environment.
- UP government subsidy agreement signed: ₹250 crores investment commitment from November 2022 to November 2026, with investment subsidy approved and letter of comfort received. The subsidy trigger is reaching ₹200 crores of investment, with no linkage to revenue, only investment and employment generation.
- Credit rating reaffirmed at A- by CARE.
- NSE listing application is at final stages; board has approved and management expects to share "good news" soon.
- Tooling inventory of ₹45-50 crores is structural rather than discretionary: tools have 6-8 month lead times and require one set on the machine, one in transit for recoating/treatment, and one standby in stores.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Full-year growth target | Revised to 16% from original 30-35% | FY25 |
| Net debt reduction | Reduce by ₹20 crores | FY25 |
| Project Titan mass production | Second trial Feb 2025; mass production start | August 2026 |
| Second new nomination mass production | Mass production start | Mid-2027 |
| UP investment subsidy trigger | Reach ₹200 crores investment to begin claiming | By November 2026 |
| European demand clarity | Management visiting Europe for face-to-face customer meetings | Before Christmas 2024 |
| NSE listing | Application at final stages | Undated ("soon") |
Key Metrics
| Metric | Q2 FY25 |
|---|---|
| Revenue | ₹105.71 cr, +2.5% YoY; flattish QoQ |
| Exports share | 71% of revenue, vs 73% last quarter |
| EBITDA | ₹22.28 cr, -11.5% YoY; flattish QoQ |
| EBITDA margin | 21.09% (H1 FY25), vs 25.09% in H1 FY24 |
| PBT | ₹6.75 cr, -50.4% YoY; -20% QoQ |
| PBT margin | 7.18% (H1 FY25), vs 13.11% in H1 FY24 |
| Gross profit margin | 71.7% (H1 FY25), vs 72.38% in H1 FY24 |
| Cash from operations | ₹19.8 cr (H1 FY25), +83% YoY |
| Overall debt | ₹305 cr, vs ₹250 cr same period last year |
| Fixed asset addition | ₹22.28 cr (H1 FY25), vs ~₹57 cr in H1 FY24 |
| Other income | ₹4.2 cr, vs ₹1–1.5 cr in prior quarters |
| Active customers | 22 |
| Active SKUs | More than 900 |
| Permanent employees | ~832 |
| Credit rating | A- (reaffirmed by CARE) |